swertisin has been researched along with sb 203580 in 1 studies
Studies (swertisin) | Trials (swertisin) | Recent Studies (post-2010) (swertisin) | Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) |
---|---|---|---|---|---|
21 | 0 | 19 | 3,489 | 4 | 1,137 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bhonde, RR; Dadheech, N; Dave, A; Gupta, S; Paranjape, N; Shah, GM; Srivastava, A | 1 |
1 other study(ies) available for swertisin and sb 203580
Article | Year |
---|---|
Swertisin an Anti-Diabetic Compound Facilitate Islet Neogenesis from Pancreatic Stem/Progenitor Cells via p-38 MAP Kinase-SMAD Pathway: An In-Vitro and In-Vivo Study.
Topics: Animals; Apigenin; Basic Helix-Loop-Helix Transcription Factors; Cell Differentiation; Cells, Cultured; Down-Regulation; Homeodomain Proteins; Humans; Hypoglycemic Agents; Imidazoles; Islets of Langerhans; Male; Mice; Mice, Inbred BALB C; Nerve Tissue Proteins; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Pyridines; Signal Transduction; Smad Proteins; Stem Cells; Trans-Activators; Transcriptional Activation | 2015 |